ESA-1121

N/A

Report date: 2025/01/26 17:00:27
NME

Base Information

Drug NameESA-1121
Drug Alias Namedual protein kinase and epigenetic target inhibitor (Guangzhou Esa Biotech)ESA-1121
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein kinases inhibitors
TargetsProtein kinases
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesGuangzhou Yingsheng Bio Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesGuangzhou Yingsheng Bio Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A